Mateo P. Porres-Aguilar

Internal Medicine

2000 Transmountain Rd Ste B
El Paso, TX 79911

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 100 publications

Key points from the 2026 multisocietal acute pulmonary embolism guidelines: Perspectives of some SVM members on the writing committee.

Key points from the 2026 multisocietal acute pulmonary embolism guidelines: Perspectives of some SVM members on the writing committee.

Journal: Vascular medicine (London, England)

Published: August 13, 2026

Right Ventricular-Protective Strategies in Pulmonary Embolism With Cardiopulmonary Failure: Prone Positioning and Mechanical Ventilation.

Right Ventricular-Protective Strategies in Pulmonary Embolism With Cardiopulmonary Failure: Prone Positioning and Mechanical Ventilation.

Journal: JACC. Case reports

Published: July 17, 2026

Cardiogenic Shock.

Cardiogenic Shock.

Journal: The New England journal of medicine

Published: March 25, 2026

Exercise for treatment and prevention of post-pulmonary embolism syndrome: A review.

Exercise for treatment and prevention of post-pulmonary embolism syndrome: A review.

Journal: Vascular medicine (London, England)

Published: March 17, 2026

Inferior Vena Cava Atresia With Extensive Central Occlusive Deep Vein Thromboses.

Inferior Vena Cava Atresia With Extensive Central Occlusive Deep Vein Thromboses.

Journal: Mayo Clinic proceedings

Published: December 17, 2025

Saddle Pulmonary Embolism in Hemodynamically Stable Patients: Clinical Implications and Unresolved Questions.

Saddle Pulmonary Embolism in Hemodynamically Stable Patients: Clinical Implications and Unresolved Questions.

Journal: Archivos de bronconeumologia

Published: December 08, 2025

Venous thromboembolism prophylaxis in the intensive care unit: Is there a future role for factor XI/XIa inhibitors as novel antithrombotic agents?

Venous thromboembolism prophylaxis in the intensive care unit: Is there a future role for factor XI/XIa inhibitors as novel antithrombotic agents?

Journal: Medicina intensiva

Published: August 13, 2025

Venous thromboembolism prevention and treatment with factor XI/XIa inhibitors: current status and future perspectives.

Venous thromboembolism prevention and treatment with factor XI/XIa inhibitors: current status and future perspectives.

Journal: Journal of thrombosis and thrombolysis

Published: June 09, 2025

Extended anticoagulation in patients with cancer-associated venous thromboembolism.

Extended anticoagulation in patients with cancer-associated venous thromboembolism.

Journal: Polish archives of internal medicine

Published: May 30, 2025

Abelacimab versus rivaroxaban in patients with atrial fibrillation: Insights into the AZALEA-TIMI 71 study.

Abelacimab versus rivaroxaban in patients with atrial fibrillation: Insights into the AZALEA-TIMI 71 study.

Journal: Revista de investigacion clinica; organo del Hospital de Enfermedades de la Nutricion

Published: March 20, 2025

Implementing the 2024 ACC/AHA Multisocietal PAD guidelines into clinical practice: Key changes from the 2016 guidelines.

Implementing the 2024 ACC/AHA Multisocietal PAD guidelines into clinical practice: Key changes from the 2016 guidelines.

Journal: Vascular medicine (London, England)

Published: December 23, 2024

Andexanet alfa for oral fxa inhibitor-associated major acute intracerebral hemorrhage: insights into clinically relevant thromboembolic events from the ANNEXA-I study.

Andexanet alfa for oral fxa inhibitor-associated major acute intracerebral hemorrhage: insights into clinically relevant thromboembolic events from the ANNEXA-I study.

Journal: Jornal vascular brasileiro

Published: September 03, 2024

Showing 1-12 of 100

Last Updated: 09/26/2026